The National Multiple Sclerosis Society today announced early progress in increasing access to comprehensive, quality care in ...

US FDA accepts Genentech’s NDA under priority review for giredestrant in ER-positive early-stage breast cancer: South San Francisco, California Wednesday, June 3, 2026, 09:00 Hr ...

Late-breaking Phase II data highlight enicepatide’s (CT-388) efficacy and safety, reinforcing its potential to deliver best-in-class weight loss across a broad population of people living with ...

Earlier this month, Genentech offered countless academics and other researchers up to $125,000 in grants to generate papers ...

Genentech recently announced a series of marketing leadership hires to start off the new year. The biotech company hired Erica Taylor, PhD, as the company’s first chief marketing officer and tabbed ...

Biotechnology company Genentech is expanding its local manufacturing capabilities with a $450 million investment in its Oceanside campus. Genentech was founded in 1976 and has been considered a ...

Immunic, Inc IMUX announced it strengthened its leadership team on Wednesday as the company prepares to advance its multiple ...

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for ...

– Exploratory long-term follow-up analysis of the Phase III POLARIX study indicated a positive trend in overall survival in favor of Polivy in combination with R-CHP for people with first-line diffuse ...

A rendering of the new biotech facility in Oceanside. Courtesy of Genentech Genentech has begun a $450 million expansion of its biotech campus in Oceanside with a new facility that will produce ...

May 15, 2026, 1:58 PM ESTHealth Care May 06, 2026, 2:10 PM ESTHealth Care March 24, 2026, 4:10 PM ESTHealth Care April 08, 2026, 7:29 PM ESTCareer & Workplace March 02, 2026, 5:35 PM ESTHealth Care ...